What makes this product unique?
Resist Triple-Action Dark Spot Eraser 2% BHA Gel is a unique treatment for those struggling with discolorations and breakouts. 2% hydroquinone lightens sun-damaged areas while 2% salicylic acid exfoliates to reduce blemishes. This anti-aging lightener restores an even skin tone by fading skin discolorations caused by the sun or hormones. The silky, breathable gel texture is ideal for normal to oily skin. The formula glides on easily and absorbs without feeling sticky or greasy. Special packaging keeps key sensitive ingredients stable and prevents product discoloration. You'll see improved skin texture and clarity.
This product is 100% fragrance- and colorant-free with a pH range of 3.5-3.9.
Who is this product for?
Resist Triple-Action Dark Spot Eraser 2% BHA Gel is formulated for anyone struggling with skin discolorations, uneven skin tone from sun damage, and breakouts. It is best suited for normal to oily or combination skin.
NOTE: Those allergic to aspirin (acetylsalicylate) should not use products containing salicylic acid (beta hydroxy acid).
Sources to support the claims made for Resist Triple-Action Dark Spot Eraser 2% BHA Gel
Cutis, April 2008, pages 356–371 and August 2006, pages S6–S19; Journal of Cosmetic Laser Therapy, September 2006, pages 121–127; American Journal of Clinical Dermatology, July 2006, pages 223–230; and Journal of the American Academy of Dermatology, May 2006, pages S272–S281; Journal of Drugs in Dermatology, September–October 2005, pages 592–597; Experimental Dermatology, January 2005, pages 34–40; April 2003, Supplemental, pages 57–63; and January 2003, pages S43–S50; Cancer Letters, December 2002, pages 125–135; Journal of Dermatological Science, August, 2001, Supplemental, pages 68–75; Molecular Carcinogenesis, July 2001, pages 152–160; Dermatologic Surgery, May 2001, page 429; and Dermatology, 1999, volume 199, number 1, pages 50–53; and Cosmetic Dermatology Principles and Practice 2nd Edition, McGraw Hill Medical Publishing, Leslie Baumann MD, 2009, pages 150–151 and page 316.
Epilobium angustifolium extract, licorice extract, hydroquinone, superoxide dismutase, aloe juice, salicylic acid, Aloe barbadensis, allantoin, glycerin, anti-irritant, BHA (beta hydroxy acid), dipotassium glycyrrhizate
Active Ingredient: Hydroquinone 2% (melanin inhibitor)
Other Ingredients: Water, Ethoxydiglycol (solvent), Butylene Glycol (slip agent/water-binding agent), Salicylic Acid (beta hydroxy acid/exfoliant), Aloe Barbadensis Leaf Juice (water-binding agent), Epilobium Angustifolium Flower/Leaf/Stem Extract, Dipotassium Glycyrrhizate (anti-irritants), Glycerin (skin-identical ingredient), Superoxide Dismutase (antioxidant), Allantoin (anti-irritant), Caprylyl Glycol, Hexylene Glycol (skin-conditioning agents), Hydroxyethylcellulose (gel-based thickener), Sodium Metabisulfite, Sodium Sulfite (stabilizers), Sodium Hydroxide (pH adjuster), Polyquaternium-10 (thickener), Phytic Acid (antioxidant), Phenoxyethanol (preservative).
DIRECTIONS: Apply once or twice daily to cleansed, toned skin. Spread a thin layer over areas where discolorations and breakouts are a concern. During the day, follow with the appropriate Paula's Choice sunscreen (essential to prevent discolorations from recurring). At night, follow with Resist Anti-Aging Clear Skin Hydrator and/or Resist Super Antioxidant Concentrate Serum. Results for discolorations should appear after 8–12 weeks of consistent use.
For best results, do not use hydroquinone (the active ingredient in our Resist Triple-Action Dark Spot Eraser Lotion & Gel) and benzoyl peroxide (the active ingredient in our Clear Skin Clearing Treatments) at the same time. A temporary dark staining of the skin may occur. If accidentally used together, wash the skin with soap and water to remove the staining.
Detailed instructions on how/when to apply your Paula's Choice products can be found in our How to Put Together Your Own Skincare Routine article.
What is the difference between the Resist Triple-Action Dark Spot Eraser 2% BHA Gel and Resist Triple-Action Dark Spot Eraser 7% AHA Lotion?
The main differences are texture (gel vs. lotion) and the type of exfoliant included in the formula. Resist Triple-Action Dark Spot Eraser 2% BHA Gel was designed with normal to oily skin in mind, so it contains salicylic acid (BHA) which is preferred over AHAs for that skin type. Resist Triple-Action Dark Spot Eraser 7% AHA Lotion contains glycolic acid and is ideal for someone with normal to dry skin. Both work to provide smoother, younger-looking skin.
Can I use an AHA or BHA in combination with either one of the skin lighteners?
Using an additional exfoliant may not be necessary with either skin lightening product, because both already contain them. However, if you prefer, you can alternate use of one of our AHA or BHA products with either skin lightener. If you're spot-applying one of our skin lighteners, then you can apply your regular AHA or BHA exfoliant to the rest of your face.
At what point in my routine do I apply the skin-lightening product?
Whether you're using our Resist Triple-Action Lotion or Gel, either product should be applied to dark spots or uneven areas twice daily after cleansing, toning, and exfoliating. In the morning, follow with serum and moisturizer with sunscreen. At night, follow with serum and moisturizer.
If you're using a prescription retinoid product at night, apply that first, then follow with the Dark Spot Eraser.
I have heard/read from sources that hydroquinone is carcinogenic (cancer-causing) and the FDA wants to ban it. What does Paula think of that?
Paula has written about this topic on her Web site and in her books, but the summation is that the negative research about hydroquinone and the frightening assertions being levied in the media are not related to how this effective ingredient is used in skincare products sold in the United States. It has been, and still is, the most effective topical agent for fading and/or eliminating sun- or hormone-induced brown skin discolorations and there is copious research to support this conclusion (Sources: Cutis, August 2006, Supplemental pages 6–19; Journal of Cosmetic Laser Therapy, September 2006, pages 121–127; American Journal of Clinical Dermatology, July 2006, pages 223–230; and Journal of the American Academy of Dermatology, May 2006, Supplemental, pages 272–281).